Form 483

Strides Pharma Science Limited Form 483, 2020-03-05

FDA issued a Form 483 to Strides Pharma Science Limited on 2020-03-05 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Strides Pharma Science Limited · Bangalore, India · Issued March 5, 2020

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 Mar 2020
21 CFR 211.105(b)

Distinctive ID or code not recorded in batch record

Cited by Jennifer L Huntington

5 Mar 2020
21 CFR 211.105(b)

Distinctive ID or code not recorded in batch record

Cited by Jennifer L Huntington

5 Mar 2020
21 CFR 211.63

Equipment Design, Size and Location

Cited by Jennifer L Huntington

5 Mar 2020
21 CFR 211.63

Equipment Design, Size and Location

Cited by Jennifer L Huntington

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.105(b)Cited across public-safe Form 483 observations2x
21 CFR 211.63Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere